PRMT5 and breast cancer: Also, breast cancer cells treated with GSK591 showed decreased TCF3 exon 18A/18B ratio under hypoxia which indicated that PRMT5-mediated symmetric dimethylation is important for regulation of TCF3 alternative splicing event.